You are here: Home 
Features Meters & CGMs
A conversation with Dr. Aaron Kowalski, Vice President of Treatment Therapies at JDRF, touches on ongoing work in creating an artificial pancreas, developing more rapidly-absorbed insulins, and making a stable, liquid glucagon for bi-hormonal pumps. This isn’t research for its own sake: these days, a clear “path to market” is a hallmark of JDRF research grants.
Few, if any, people can match Terry Gregg’s perspective on both the business and technology of continuous glucose monitoring. IN sat down with Gregg for this interview at the Consumer Electronics Show in Las Vegas in January 2013.
ACCU-CHEK Meters Also Receive Highest Marks in Performance, Ease of Use, Cost of Test Strips and Training
INDIANAPOLIS — Adults living with diabetes in the United States reported highest satisfaction using Roche Diabetes Care’s ACCU-CHEK products compared with other blood glucose meter manufacturers, according to the inaugural J.D. Power and Associates 2012 Blood Glucose Meter Satisfaction StudySM.
“Managing my blood sugar is the biggest challenge during training and during a race because with exercise your body becomes more efficient at using insulin. Until recently I had been testing 70-80 times during an Iron Man race. That can be annoying at 20 miles/hour on a bike or trying to run a marathon.”
Recently I have been thinking more about Continuous Glucose Monitoring because understanding trends is the most important part of managing my blood sugar during training or racing. I have been using the Dexcom unit for a week now and I can’t believe how effective a CGM is and wonder why I have not been on this sooner. I don’t have to fumble for a test strip, its just in my hand and I know immediately.
Andy Holder, AKA “Iron Andy,” Used Finger Sticks 60 times during an Ironman Triathlon. Dexcom to the rescue!
“Connected Care” Puts Expert Advice In The Palm of Your Hand
When the history of the first successful closed-loop diabetes management system is written, David Damiano’s name may be mentioned only in passing. This will not be surprising, since David, age 13, played no role in writing the algorithms and testing the meshed technologies that will make life infinitely easier and safer for people with type 1 diabetes. He is, however, the principal reason the system will exist. His father, Ed, coinvented the “bionic pancreas” to keep him safe. The system will represent a father’s love, distilled into a mathematical formula.
